Skip to main content
Press release February 25, 2026

Hayward Holdings Reports Fourth Quarter Fiscal Year 2025 Financial Results and Introduces 2026 Guidance

Hayward Holdings, Inc. (HAYW)

Hayward Holdings Reports Fourth Quarter Fiscal Year 2025 Financial Results and Introduces 2026 Guidance 02/25/2026 FOURTH QUARTER FISCAL 2025 SUMMARY Net Sales increased 7% year-over-year to $349.4 million Net Income increased 25% year-over-year to $68.4 million Adjusted EBITDA* increased 4% year-over-year to $102.9 million Diluted EPS increased 24% year-over-year to $0.31 Adjusted diluted EPS* increased 7% year-over-year to $0.29 FULL FISCAL YEAR 2025 HIGHLIGHTS Net Sales increased 7% year-over-year to $1,122.2 million Net Income increased 28% year-over-year to $151.6 million Adjusted EBITDA* increased 8% year-over-year to $299.3 million Diluted EPS and adjusted diluted EPS* of $0.68 and $0.77, increased 26% and 15%, respectively Net cash provided by operating activities increased 21% year-over-year to $256.0 million Hayward Holdings, Inc. (NYSE: HAYW) (“Hayward” or the “Company”), a leading global designer and manufacturer of a broad portfolio of pool equipment, outdoor living products and industrial flow control products, today announced financial results for the fourth quarter and full fiscal year ended December 31, 2025. CEO COMMENTS “Hayward delivered a strong fourth quarter, outperforming expectations and building on our momentum,” said Kevin Holleran, Hayward’s President and Chief Executive Officer. “Our team executed at a high level across the organization, driving an exceptional finish to 2025, with solid in-quarter demand and strong participation in our Early Buy programs for the upcoming 2026 pool season. Full year net sales increased 7% year‑over‑year, reflecting solid performance across both our North America and Europe & Rest of World segments, as well as the strength of our aftermarket model. We expanded margins through operational efficiencies and successful mitigation of new tariffs and other inflationary pressures, while continuing to invest strategically in product innovation and customer support. Impressive cash flow generation further strengthened our balance sheet and enabled a meaningful reduction in net leverage. With industry‑leading products, a customer‑centric approach, and ongoing investments in technology and operational efficiency, Hayward is well positioned to capitalize on the long‑term growth drivers of the pool industry and continue delivering value for our stockholders.” BASIS OF PRESENTATION During the fourth quarter of Fiscal Year 2025, the Company changed its presentation of warranty costs from selling, general and administrative to cost of sales within the consolidated statements of operations. Tables outlining this presentation change are included near the end of this release. This change in presentation has been applied retrospectively to all periods presented and affects cost of sales, gross profit and selling, general and administrative expense. This change in presentation has no impact to net sales, operating income, income from operations before income taxes, income tax expense, net income, net income per common share, retained earnings, other components of equity, net assets, or cash flows. FOURTH QUARTER FISCAL 2025 CONSOLIDATED RESULTS Net sales increased by 7% to $349.4 million for the fourth quarter of fiscal 2025. The increase in net sales during the quarter was driven by positive net price to offset inflation and tariffs and the favorable impact from foreign currency translation, partially offset by a modest decrease in volume. Gross profit increased by 10% to $169.3 million for the fourth quarter of fiscal 2025. Gross profit margin increased 160 basis points to 48.5%. Gross profit margin increased primarily due to higher net prices, lower warranty expenses and operational efficiencies. These gains were partially offset by higher net tariff charges and inflation. Selling, general, and administrative ("SG&A") expense increased by 14% to $67.0 million for the fourth quarter of fiscal 2025. The increase in SG&A expenses was mainly attributable to increased variable compensation, strategic investments in our selling and customer service teams and the settlement in principle related to the securities class action litigation. Research, development, and engineering expenses were $8.0 million for the fourth quarter of fiscal 2025, or 2.3% of net sales, as compared to $6.9 million for the prior-year period, or 2.1% of net sales. The increase was primarily driven by investments in product innovation. Operating income increased by 14% to $87.3 million for the fourth quarter of fiscal 2025, due to the aggregated effects of the items described above. Operating income as a percentage of net sales (“operating margin”) was 25.0% for the fourth quarter of fiscal 2025, a 160 basis point increase compared to 23.4% in the prior-year period. Interest expense, net, decreased by 14% to $11.7 million for the fourth quarter of fiscal 2025 driven by lower interest rates and increased interest income on cash deposits. Net income increased by 25% to $68.4 million for the fourth quarter of fiscal 2025. Net income margin expanded 290 basis points to 19.6%. Adjusted net income* increased by 8.6% to $64.3 million for the fourth quarter of fiscal 2025. Adjusted net income margin* increased 30 basis points to 18.4%. Adjusted EBITDA* increased by 4% to $102.9 million for the fourth quarter of fiscal 2025 compared to $98.7 million in the prior-year period. Adjusted EBITDA margin* decreased 80 basis points to 29.4%. Diluted EPS increased by 24% to $0.31 for the fourth quarter of fiscal 2025. Adjusted diluted EPS* increased by 7.4% to $0.29 for the fourth quarter of fiscal 2025. FOURTH QUARTER FISCAL 2025 SEGMENT RESULTS North America Net sales increased by 8% to $308.7 million for the fourth quarter of fiscal 2025. The increase was driven by positive net price to offset inflation and tariffs, partially offset by a modest decline in volume. Segment income increased by 8% to $102.5 million for the fourth quarter of fiscal 2025. Adjusted segment income* increased by 4% to $109.2 million. Europe & Rest of World Net sales decreased by 1% to $40.7 million for the fourth quarter of fiscal 2025. The decrease was primarily due to a decrease in volume and net price, partially offset by the favorable impact of foreign currency translation. Segment income increased by 28% to $6.2 million for the fourth quarter of fiscal 2025. Adjusted segment income* increased by 26% to $6.6 million. FULL FISCAL YEAR 2025 CONSOLIDATED RESULTS Net sales increased by 7% to $1,122.2 million for Fiscal Year 2025. The increase in net sales was primarily driven by positive net price and the favorable impact from acquisitions. The increase in net price was due to price increases enacted to offset inflationary and tariff pressures. Gross profit increased by 11% to $538.7 million for Fiscal Year 2025. Gross profit margin increased to 48.0% for Fiscal Year 2025, an increase of 170 basis points compared to Fiscal Year 2024. This growth was driven by positive pricing, lower warranty costs and improved manufacturing efficiency, though partially offset by higher net tariffs and inflation. SG&A expense increased by 14% to $246.9 million for Fiscal Year 2025. The increase was mainly caused by higher variable compensation, higher wage inflation, investments in our selling and customer service teams, plus a full year of expense from the ChlorKing HoldCo, LLC and related entities business ("ChlorKing") acquired in June 2024. Research, development, and engineering expenses were $27.2 million for Fiscal Year 2025, or 2.4% of net sales, as compared to $25.8 million for Fiscal Year 2024, or 2.5% of net sales. Operating income increased by 12% to $233.3 million for Fiscal Year 2025. The increase in operating income was driven by the accumulated effect of the items described above. Operating margin was 20.8% in Fiscal Year 2025, a 90 basis point increase from the 19.9% operating margin in Fiscal Year 2024. Net income increased by 28% to $151.6 million for Fiscal Year 2025. Adjusted net income* increased by 15% to $170.5 million compared to Fiscal Year 2024. Net income margin expanded 220 basis points to 13.5% and adjusted net income margin* increased 110 basis points to 15.2%. Adjusted EBITDA* increased by 8% to $299.3 million for Fiscal Year 2025 driven primarily by an increase in net sales and gross profit, partially offset by an increase in SG&A expenses. Adjusted EBITDA margin* increased by 30 basis points to 26.7% for Fiscal Year 2025 compared to Fiscal Year 2024. Diluted EPS increased by 26% to $0.68 for the Fiscal Year 2025. Adjusted diluted EPS* increased by 15% to $0.77 for Fiscal Year 2025. BALANCE SHEET AND CASH FLOW As of December 31, 2025, Hayward had cash and cash equivalents of $329.6 million, short-term investments of $69.5 million and approximately $125.5 million available for future borrowings under its revolving credit facilities. Net cash provided by operating activities for Fiscal Year 2025 of $256.0 million was an increase of $44.0 million from Fiscal Year 2024. The increase in cash provided by operating activities was primarily driven by an increase in net income and an increase in cash generated by changes in working capital compared to the prior-year period. OUTLOOK Hayward is introducing 2026 guidance reflecting continued sales and earnings growth driven by solid execution across the organization, positive price realization and continued technology adoption. For Fiscal Year 2026, Hayward expects net sales to increase approximately 4% from Fiscal Year 2025, and adjusted diluted earnings per share* of $0.82 to $0.86, or an increase of approximately 6% to 12%. Hayward is excited about the long-term dynamics of the pool industry. The installed base of pools increases every year, providing continued growth opportunities, and the Company benefits from favorable secular demand trends in outdoor living, sunbelt migration, and technology adoption. Hayward continues to leverage its competitive advantages and drive increasing adoption of its leading SmartPad™ pool equipment products both in new construction and the aftermarket, which represents approximately 85% of net sales. Hayward is confident in its long-term outlook for profitable growth and robust cash flow generation, driven by its technology leadership, operational excellence, strong brand and installed base, and multi-channel capabilities. Please see the Forward-Looking Statements section of this release for a discussion of certain risks relevant to Hayward’s outlook. CONFERENCE CALL INFORMATION Hayward will hold a conference call to discuss the results today, February 25, 2026 at 9:00 a.m. (ET). Interested investors and other parties can listen to a webcast of the live conference call by logging onto the Investor Relations section of the Company’s website at https://investor.hayward.com/events-and-presentations/default.aspx. An earnings presentation will be posted to the Investor Relations section of the Company’s website prior to the conference call. The conference call can also be accessed by dialing (877) 423-9813 or (201) 689-8573. For those unable to listen to the live conference call, a replay will be available approximately three hours after the call through the archived webcast on the Hayward website or by dialing (844) 512-2921 or (412) 317-6671. The access code for the replay is 13758285. The replay will be available until 11:59 p.m. Eastern Time on March 11, 2026. ABOUT HAYWARD HOLDINGS, INC. Hayward Holdings, Inc. (NYSE: HAYW) is a leading global designer and manufacturer of a broad portfolio of pool equipment, outdoor living products and industrial flow control products. With a mission to deliver exceptional products, outstanding service and innovative solutions to transform the experience of water, Hayward offers a full line of energy-efficient and sustainable residential and commercial pool equipment including pumps, heaters, sanitizers, filters, LED lighting, water features, and cleaners all digitally connected through Hayward’s intuitive IoT-enabled SmartPad™, and a line of thermoplastic valves and process control products. CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS Unless otherwise indicated, the terms “Company,” “we,” “our” and “us” refer to Hayward Holdings, Inc. and its consolidated subsidiaries. This earnings release contains certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Act”) and rules and regulations of the Securities and Exchange Commission (“SEC”). Forward-looking statements include, without limitation, statements regarding our plans, strategies, objectives, expectations, intentions, outlook, expenditures, guidance, targets, and assumptions, as well as other statements that are not historical facts. Forward-looking statements are based on management’s current beliefs, assumptions, expectations, and information available at the time the statements are made. Words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intend,” “may,” “outlook,” “plan,” “potential,” “predict,” “project,” “seek,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these words. These statements are made in reliance upon the safe harbor provisions of the Act. However, forward-looking statements are subject to risks, uncertainties, and other factors, many of which are beyond our control, that could cause actual results to differ materially from those expressed or implied by such statements. Readers are cautioned not to place undue reliance on forward-looking statements. We undertake no obligation to publicly update, revise, or correct any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable federal securities laws. Forward-looking statements should be read in conjunction with the risk factors and other cautionary statements, including those described under the heading "Risk Factors" in our most recent Annual Report on Form 10-K and other filings with the SEC. Important factors that could cause actual results to differ materially include, but are not limited to, the following: our business depends on the performance of distributors, builders, buying groups, retailers and servicers;the demand for our products may be adversely affected by unfavorable economic and business conditions;we operate in markets with high levels of competition;our future success depends on developing, manufacturing and attaining market adoption of new products and maintaining product quality and reliability;our ability to keep pace with rapidly evolving technological developments and standards, including artificial intelligence (“AI”), and effectively develop and deploy such technologies;our results of operations and cash flows may fluctuate from quarter to quarter;a loss of, or material cancellation, reduction or delay in purchases by one or more of our largest customers;our exposure to credit risk on our accounts receivable;risks arising from our international business operations;past growth may not be indicative of future growth;our inability to identify, finance and complete suitable acquisitions;negative impacts of litigation and other claims;future impairment of our goodwill and intangible assets;exchange rate fluctuations, cost increases and other inflation, changes in our effective tax rate or exposure to additional income tax liabilities;our ability to attract, develop and retain highly qualified personnel, including key members of management;disruptions in the financial markets;significant disruption or breach of our technology infrastructure or that of our vendors or third parties, or failure to maintain the security of confidential information;difficulties in operating or implementing the new ERP system or human resources information system;misuse of our technology-enabled products;failure to maintain an effective system of internal controls;dependence on key suppliers, including single-source suppliers and sole-source suppliers;ability to manage product inventory in an effective and efficient manner;product manufacturing disruptions, including as a result of catastrophic or other events beyond our control;tariffs and other trade restrictions and the cost of raw materials;compliance with, and potential liabilities under employment, environment, health, transportation, safety and other governmental laws and regulations;risks related to our handling of personal information;our employees, commercial partners and vendors may engage in misconduct or other improper activities;violations of the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act, and other anti-corruption laws;our failure to comply with international trade compliance regulations, and changes in U.S. government sanctions;changes in laws, regulations, government policies or regulatory interpretations;climate change and legal or regulatory responses thereto, and increasing scrutiny from stakeholders on environmental, social and other sustainability matters;our ability to obtain, maintain and enforce our intellectual property and proprietary rights;protection of our trademarks or trade names;our reliance on access to intellectual property owned by third parties;claims that our employees, consultants or advisors have wrongfully used or disclosed alleged trade secrets or other proprietary information or claims asserting ownership of intellectual property that we regard as our own;our ability to enforce our intellectual property rights in all jurisdictions;other risks related to our indebtedness, corporate structure and ownership of our common stock; andother factors described in the Risk Factors section of our Annual Report on Form 10-K for the year ended December 31, 2025. Many of these factors are beyond our control. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, actual results, performance, or achievements may differ materially from those expressed or implied by forward-looking statements in this earnings release. The forward-looking statements included in this earnings release speak only as of the date of this release. *NON-GAAP FINANCIAL MEASURES This earnings release includes certain financial measures not presented in accordance with the generally accepted accounting principles in the United States (“GAAP”), including adjusted net income, adjusted net income margin, adjusted basic EPS, adjusted diluted EPS, EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted segment income and adjusted segment income margin. These financial measures are not measures of financial performance in accordance with GAAP and may exclude items that are significant in understanding and assessing the Company’s financial results. Hayward believes these non-GAAP measures provide analysts, investors and other interested parties with additional insight into the underlying trends of its business and assist these parties in analyzing the Company’s performance across reporting periods on a consistent basis by excluding items that it does not believe are indicative of its core operating performance, which allows for a better comparison against historical results and expectations for future performance. Management uses these non-GAAP measures to understand and compare operating results across reporting periods for various purposes including internal budgeting and forecasting, short and long-term operating planning, employee incentive compensation, and debt compliance. These measures should not be considered in isolation or as an alternative to net income, segment income or other measures of profitability, performance or financial condition under GAAP. You should be aware that the Company’s presentation of these measures may not be comparable to similarly titled measures used by other companies, which may be defined and calculated differently. See the appendix for a reconciliation of historical non-GAAP measures to the most directly comparable GAAP measures. Reconciliation of full fiscal year 2026 adjusted diluted earnings per share outlook to diluted earnings per share is not being provided, as Hayward does not currently have sufficient data to accurately estimate the variables and individual adjustments for such reconciliation. The outlook for adjusted diluted earnings per share for full year 2026 is calculated in a manner consistent with the historical presentation of these measures, as shown in the appendix. Hayward Holdings, Inc. Consolidated Balance Sheets (In thousands) December 31, 2025 December 31, 2024 Assets Current assets Cash and cash equivalents $ 329,648 $ 196,589 Short-term investments 69,462 — Accounts receivable, net of allowances of $1,931 and $2,701, respectively 280,161 278,582 Inventories, net 210,739 216,472 Prepaid expenses 19,500 20,203 Income tax receivable 656 6,426 Other current assets 41,080 48,697 Total current assets 951,246 766,969 Property, plant, and equipment, net of accumulated depreciation of $125,807 and $112,099, respectively 164,560 160,377 Goodwill 951,197 943,645 Trademark 736,000 736,000 Customer relationships, net 178,126 198,333 Other intangibles, net 88,899 96,095 Other non-current assets 80,956 89,205 Total assets $ 3,150,984 $ 2,990,624 Liabilities and Stockholders’ Equity Current liabilities Current portion of long-term debt $ 13,261 $ 13,991 Accounts payable 77,007 81,476 Accrued expenses and other liabilities 224,222 217,242 Income taxes payable 8,754 273 Total current liabilities 323,244 312,982 Long-term debt, net 943,547 950,562 Deferred tax liabilities, net 227,449 239,111 Other non-current liabilities 63,736 64,322 Total liabilities 1,557,976 1,566,977 Stockholders’ equity Preferred stock, $0.001 par value, 100,000,000 authorized, no shares issued or outstanding as of December 31, 2025 and December 31, 2024 — — Common stock $0.001 par value, 750,000,000 authorized; 246,272,783 issued and 217,356,414 outstanding at December 31, 2025; 244,444,889 issued and 215,778,520 outstanding at December 31, 2024 247 245 Additional paid-in capital 1,109,522 1,093,468 Common stock in treasury; 28,916,369 and 28,666,369 at December 31, 2025 and December 31, 2024, respectively (363,182 ) (358,133 ) Retained earnings 851,134 699,564 Accumulated other comprehensive loss (4,713 ) (11,497 ) Total stockholders’ equity 1,593,008 1,423,647 Total liabilities and stockholders’ equity $ 3,150,984 $ 2,990,624 Hayward Holdings, Inc. Unaudited Condensed Consolidated Statements of Operations (Dollars in thousands, except per share data) Three Months Ended Year Ended December 31, 2025 December 31, 2024 December 31, 2025 December 31, 2024 Net sales $ 349,375 $ 327,075 $ 1,122,155 $ 1,051,606 Cost of sales 180,093 173,781 583,465 564,630 Gross profit 169,282 153,294 538,690 486,976 Selling, general and administrative expense 67,021 58,548 246,892 217,147 Research, development and engineering expense 7,965 6,908 27,201 25,778 Acquisition and restructuring related expense 119 3,976 3,886 6,464 Amortization of intangible assets 6,874 7,375 27,461 28,800 Operating income 87,303 76,487 233,250 208,787 Interest expense, net 11,665 13,563 50,282 62,163 Loss on debt extinguishment — — — 4,926 Other expense (income), net 327 (495 ) (1,669 ) (2,484 ) Total other expense 11,992 13,068 48,613 64,605 Income from operations before income taxes 75,311 63,419 184,637 144,182 Provision for income taxes 6,901 8,686 33,067 25,527 Net income $ 68,410 $ 54,733 $ 151,570 $ 118,655 Earnings per share Basic $ 0.32 $ 0.25 $ 0.70 $ 0.55 Diluted $ 0.31 $ 0.25 $ 0.68 $ 0.54 Weighted average common shares outstanding Basic 217,159,379 215,584,373 216,593,972 215,028,683 Diluted 222,531,701 221,872,482 222,225,777 221,370,188 Hayward Holdings, Inc. Consolidated Statements of Cash Flows (In thousands) Year Ended December 31, 2025 December 31, 2024 Cash flows from operating activities Net income $ 151,570 $ 118,655 Adjustments to reconcile net income to net cash provided by operating activities Depreciation 22,835 20,078 Amortization of intangible assets 34,451 35,783 Amortization of deferred debt issuance fees 3,763 4,203 Stock-based compensation 13,389 10,595 Deferred income taxes (benefit) (7,751 ) (10,514 ) Allowance for credit losses (770 ) (169 ) Loss on debt extinguishment — 4,926 (Gain) loss on sale/disposal of property, plant and equipment 485 (428 ) Changes in operating assets and liabilities Accounts receivable 5,056 (7,260 ) Inventories 11,780 4,330 Other current and non-current assets 6,377 (41,167 ) Accounts payable (5,940 ) 11,794 Accrued expenses and other liabilities 20,789 61,242 Net cash provided by operating activities 256,034 212,068 Cash flows from investing activities Purchases of property, plant, and equipment (28,715 ) (22,371 ) Software development costs (1,957 ) (1,918 ) Cash paid for acquisition of businesses, net of cash acquired — (55,153 ) Cash paid for asset acquisitions (3,643 ) — Proceeds from sale of property, plant, and equipment — 311 Purchases of short-term investments (69,462 ) — Proceeds from short-term investments — 25,000 Net cash used in investing activities (103,777 ) (54,131 ) Cash flows from financing activities Proceeds from issuance of long-term debt — 2,886 Payments of long-term debt (12,810 ) (138,638 ) Proceeds from issuance of short-term notes payable — 6,340 Payments of short-term notes payable (2,169 ) (6,463 ) Debt issuance costs (1,579 ) — Purchase of common stock (5,049 ) (378 ) Other, net 761 (537 ) Net cash used in financing activities (20,846 ) (136,790 ) Effect of exchange rate changes on cash and cash equivalents 1,648 (2,655 ) Change in cash and cash equivalents 133,059 18,492 Cash and cash equivalents, beginning of period 196,589 178,097 Cash and cash equivalents, end of period $ 329,648 $ 196,589 Supplemental disclosures of cash flow information: Cash paid-interest $ 59,775 $ 68,476 Cash paid-income taxes 26,413 35,938 Non-cash investing and financing activities: Accrued and unpaid purchases of property, plant, and equipment 634 4,567 Equipment financed under finance leases 3,171 1,046 Warranty Cost Presentation Change The following tables show the impact of the warranty presentation change out of selling, general and administrative expense and into cost of sales in our unaudited consolidated statements of operations for fiscal quarters in fiscal years 2025 and 2024, respectively. (Dollars in thousands) 2025 Consolidated - As Reported Three months ended March 29, 2025 June 28, 2025 September 27, 2025 Cost of sales $ 115,466 $ 141,764 $ 119,200 Gross profit 113,375 157,839 125,136 Selling, general and administrative expense 65,117 71,893 69,803 (Dollars in thousands) 2025 Consolidated - After Change in Presentation(1) Three months ended March 29, 2025 June 28, 2025 September 27, 2025 Cost of sales $ 123,588 $ 152,149 $ 127,635 Gross profit 105,253 147,454 116,701 Selling, general and administrative expense 56,995 61,508 61,368 (1) For the three months ended December 31, 2025, $12.7 million of warranty costs were presented within cost of sales on the unaudited condensed consolidated statement of operations. (Dollars in thousands) 2024 Consolidated - As Reported Three months ended March 30, 2024 June 29, 2024 September 28, 2024 December 31, 2024 Cost of sales $ 107,990 $ 139,306 $ 114,474 $ 159,079 Gross profit 104,579 145,087 113,095 167,996 Selling, general and administrative expense 60,014 63,155 64,509 73,250 (Dollars in thousands) 2024 Consolidated - After Change in Presentation Three months ended March 30, 2024 June 29, 2024 September 28, 2024 December 31, 2024 Cost of sales $ 116,210 $ 150,971 $ 123,668 $ 173,781 Gross profit 96,359 133,422 103,901 153,294 Selling, general and administrative expense 51,794 51,490 55,315 58,548 The following tables show the adjustment of the warranty presentation change to our North America segment significant segment expenses impacted by the change including cost of sales and segment selling, general and administrative expense for fiscal quarters in fiscal year 2025 and 2024, respectively. (Dollars in thousands) 2025 North America - As Reported Three months ended March 29, 2025 June 28, 2025 September 27, 2025 Cost of sales $ 88,333 $ 114,615 $ 98,223 Segment selling, general and administrative expense 49,625 51,390 47,831 (Dollars in thousands) 2025 North America - After Change in Presentation(1) Three months ended March 29, 2025 June 28, 2025 September 27, 2025 Cost of sales $ 95,826 $ 124,335 $ 106,141 Segment selling, general and administrative expense 42,132 41,670 39,913 (1) For the three months ended December 31, 2025, $12.1 million of warranty costs were presented within cost of sales within the NAM segment. (Dollars in thousands) 2024 North America - As Reported Three months ended March 30, 2024 June 29, 2024 September 28, 2024 December 31, 2024 Cost of sales $ 83,552 $ 113,683 $ 93,092 $ 130,896 Segment selling, general and administrative expense 44,161 46,325 44,200 53,335 (Dollars in thousands) 2024 North America - After Change in Presentation Three months ended March 30, 2024 June 29, 2024 September 28, 2024 December 31, 2024 Cost of sales $ 91,069 $ 124,488 $ 101,695 $ 144,972 Segment selling, general and administrative expense 36,644 35,520 35,597 39,259 The following tables show the adjustment of the warranty presentation change to our Europe & Rest of World segment significant segment expenses impacted by the change including cost of sales and segment selling, general and administrative expense for fiscal quarters in fiscal year 2025 and 2024, respectively. (Dollars in thousands) 2025 Europe & Rest of World - As Reported Three months ended March 29, 2025 June 28, 2025 September 27, 2025 Cost of sales $ 27,133 $ 27,149 $ 20,977 Segment selling, general and administrative expense 7,772 9,358 8,549 (Dollars in thousands) 2025 Europe & Rest of World - After Change in Presentation(1) Three months ended March 29, 2025 June 28, 2025 September 27, 2025 Cost of sales $ 27,762 $ 27,814 $ 21,494 Segment selling, general and administrative expense 7,143 8,693 8,032 (1) For the three months ended December 31, 2025, $0.6 million of warranty costs were presented within cost of sales within the E&RW segment. (Dollars in thousands) 2024 Europe & Rest of World - As Reported Three months ended March 30, 2024 June 29, 2024 September 28, 2024 December 31, 2024 Cost of sales $ 24,438 $ 25,623 $ 21,382 $ 28,183 Segment selling, general and administrative expense 8,338 9,019 8,402 7,832 (Dollars in thousands) 2024 Europe & Rest of World - After Change in Presentation Three months ended March 30, 2024 June 29, 2024 September 28, 2024 December 31, 2024 Cost of sales $ 25,141 $ 26,483 $ 21,973 $ 28,809 Segment selling, general and administrative expense 7,635 8,159 7,811 7,206 Reconciliations Consolidated Reconciliations Adjusted EBITDA and Adjusted EBITDA Margin Reconciliations (Non-GAAP) Following is a reconciliation from net income to adjusted EBITDA: (Dollars in thousands) Three Months Ended Year Ended December 31, 2025 December 31, 2024 December 31, 2025 December 31, 2024 Net income $ 68,410 $ 54,733 $ 151,570 $ 118,655 Depreciation 5,809 6,149 22,835 20,078 Amortization 8,643 9,484 34,451 35,783 Interest expense, net 11,665 13,563 50,282 62,163 Income taxes 6,901 8,686 33,067 25,527 Loss on debt extinguishment — — — 4,926 EBITDA 101,428 92,615 292,205 267,132 Stock-based compensation(a) — 52 57 608 Currency exchange items (b) (159 ) (366 ) 79 (836 ) Acquisition and restructuring related expense, net (c) 119 3,976 3,886 6,464 Other (d) 1,487 2,422 3,052 4,079 Total Adjustments 1,447 6,084 7,074 10,315 Adjusted EBITDA $ 102,875 $ 98,699 $ 299,279 $ 277,447 Net income margin 19.6 % 16.7 % 13.5 % 11.3 % Adjusted EBITDA margin 29.4 % 30.2 % 26.7 % 26.4 % (a) Represents non-cash stock-based compensation expense related to equity awards issued to management, employees, and directors. The adjustment includes only expense related to awards issued under the 2017 Equity Incentive Plan, which were awards granted prior to the effective date of Hayward’s initial public offering (the “IPO”). (b) Represents unrealized non-cash (gains) losses on foreign denominated monetary assets and liabilities and foreign currency contracts. (c) Adjustments in the fiscal quarter ended December 31, 2025 are primarily driven by $0.1 million of costs related to transaction costs for an asset acquisition closed during the fourth quarter. Adjustments in the fiscal quarter ended December 31, 2024 are primarily driven by $2.9 million of compensation expenses for the retention of key employees acquired in the ChlorKing acquisition. Pursuant to the ChlorKing acquisition agreement, this $3.2 million was part of a total $6.3 million employee retention payment that was deposited into an escrow account on the date of acquisition. The full amount held in escrow was released to the specified key employees if such employees were employed by Hayward on the one-year anniversary of the acquisition. These payments were contingent on continued employment and were not dependent on the achievement of any metric or performance measure. The retention costs were recognized over the 12-month period from the date of acquisition. Additionally, there were $0.9 million of termination benefits related to a reduction-in-force within E&RW and $0.1 million of transaction and integration costs associated with the acquisition of the ChlorKing business. Adjustments in the year ended December 31, 2025 are primarily driven by $3.1 million of compensation expenses for the retention of key employees acquired in the ChlorKing acquisition pursuant to the conditions in the acquisition agreement discussed above. Other adjustments for the year ended December 31, 2025 include $0.4 million of costs related to restructuring actions in E&RW, $0.3 million of separation costs for the consolidation of operations in North America and $0.2 million of other acquisition and integration costs, partially offset by a reduction in expense of $0.2 million to finalize the relocation of the Company's corporate office functions to Charlotte, North Carolina from Berkeley Heights, New Jersey. Adjustments in the year ended December 31, 2024 are primarily driven by $3.2 million of compensation expenses for the retention of key employees acquired in the ChlorKing acquisition pursuant to the conditions in the acquisition agreement discussed above. Other adjustments for the year ended December 31, 2024 include $1.1 million of transaction and integration costs associated with the acquisition for the ChlorKing business, $0.9 million of termination benefits related to a reduction-in-force within E&RW, $0.8 million of separation and other costs associated with the centralization and consolidation of operations in Europe and $0.4 million of costs to finalize restructuring actions initiated in prior years. (d) Adjustments in the fiscal quarter ended December 31, 2025 are driven by $1.5 million for the settlement in principle of the securities class action litigation. Additional expenses will be paid by the Company's insurance carriers pursuant to the Company's retention amount with its insurance carriers. Adjustments in the fiscal quarter ended December 31, 2024 are primarily driven by a $1.6 million increase in cost of goods sold resulting from the fair value inventory step-up adjustment recognized as part of the purchase accounting for the acquisition of the ChlorKing business and $0.7 million of costs sustained from flood damage associated with a hurricane at a contract manufacturing facility. Adjustments in the year ended December 31, 2025 primarily include $4.3 million for the settlement in principle of the securities class action litigation. Expenses beyond the $4.3 million related to this case are subject to insurance recoveries pursuant to the Company’s retention amount with its insurance carriers. Other adjustments include $1.3 million of income from insurance proceeds related to flood damage associated with a hurricane at a contract manufacturing facility. Adjustments in the year ended December 31, 2024 are primarily driven by a $3.3 million increase in cost of goods sold resulting from the fair value inventory step-up adjustment recognized as part of the purchase accounting for the acquisition of the ChlorKing business, $0.7 million of costs sustained from flood damage associated with a hurricane at a contract manufacturing facility and $0.5 million of costs incurred related to litigation, partially offset by $0.5 million of gains on the sale of assets. Adjusted Net Income and Adjusted EPS Reconciliation (Non-GAAP) Following is a reconciliation of net income to adjusted net income and earnings per share to adjusted earnings per share: (Dollars in thousands, except per share data) Three Months Ended Year Ended December 31, 2025 December 31, 2024 December 31, 2025 December 31, 2024 Net income $ 68,410 $ 54,733 $ 151,570 $ 118,655 Tax adjustments(a) (11,697 ) (7,167 ) (12,369 ) (9,389 ) Other adjustments and amortization: Stock-based compensation(b) — 52 57 608 Currency exchange items (c) (159 ) (366 ) 79 (836 ) Acquisition and restructuring related expense, net (d) 119 3,976 3,886 6,464 Other (e) 1,487 2,422 3,052 4,079 Total other adjustments 1,447 6,084 7,074 10,315 Loss on debt extinguishment — — — 4,926 Amortization 8,643 9,484 34,451 35,783 Tax effect(f) (2,492 ) (3,892 ) (10,219 ) (12,356 ) Adjusted net income $ 64,311 $ 59,242 $ 170,507 $ 147,934 Weighted average number of common shares outstanding, basic 217,159,379 215,584,373 216,593,972 215,028,683 Weighted average number of common shares outstanding, diluted 222,531,701 221,872,482 222,225,777 221,370,188 Basic EPS $ 0.32 $ 0.25 $ 0.70 $ 0.55 Diluted EPS $ 0.31 $ 0.25 $ 0.68 $ 0.54 Adjusted basic EPS $ 0.30 $ 0.27 $ 0.79 $ 0.69 Adjusted diluted EPS $ 0.29 $ 0.27 $ 0.77 $ 0.67 (a) Tax adjustments for the three and twelve months ended December 31, 2025 reflect a normalized tax rate of 24.7% and 24.6%, respectively, compared to the Company’s effective tax rate of 9.2% and 17.9%, respectively. The Company’s effective tax rate for the three and twelve months ended December 31, 2025 is primarily driven by a decrease in the applicable state tax rate on certain deferred income. Tax adjustments for the three and twelve months ended December 31, 2024 reflect a normalized tax rate of 25% and 24.2%, respectively, compared to the Company's effective tax rate of 13.7% and 17.7%, respectively. The Company’s effective tax rate for the three and twelve months ended December 31, 2024 primarily includes the tax benefits resulting from prior period return-to-provision adjustments, revaluation of deferred tax liabilities as a result of state tax changes, and the exercise of stock options along with other miscellaneous items. (b) Represents non-cash stock-based compensation expense related to equity awards issued to management, employees, and directors. The adjustment includes only expense related to awards issued under the 2017 Equity Incentive Plan, which were awards granted prior to the effective date of the IPO. (c) Represents unrealized non-cash (gains) losses on foreign denominated monetary assets and liabilities and foreign currency contracts. (d) Adjustments in the fiscal quarter ended December 31, 2025 are primarily driven by $0.1 million of costs related to transaction costs for an asset acquisition closed during the fourth quarter. Adjustments in the fiscal quarter ended December 31, 2024 are primarily driven by $2.9 million of compensation expenses for the retention of key employees acquired in the ChlorKing acquisition. Pursuant to the ChlorKing acquisition agreement, this $3.2 million was part of a total $6.3 million employee retention payment that was deposited into an escrow account on the date of acquisition. The full amount held in escrow was released to the specified key employees if such employees were employed by Hayward on the one-year anniversary of the acquisition. These payments were contingent on continued employment and were not dependent on the achievement of any metric or performance measure. The retention costs were recognized over the 12-month period from the date of acquisition. Additionally, there were $0.9 million of termination benefits related to a reduction-in-force within E&RW and $0.1 million of transaction and integration costs associated with the acquisition of the ChlorKing business. Adjustments in the year ended December 31, 2025 are primarily driven by $3.1 million of compensation expenses for the retention of key employees acquired in the ChlorKing acquisition pursuant to the conditions in the acquisition agreement discussed above. Other adjustments for the year ended December 31, 2025 include $0.4 million of costs related to restructuring actions in E&RW, $0.3 million of separation costs for the consolidation of operations in North America and $0.2 million of other acquisition and integration costs, partially offset by a reduction in expense of $0.2 million to finalize the relocation of the Company's corporate office functions to Charlotte, North Carolina from Berkeley Heights, New Jersey. Adjustments in the year ended December 31, 2024 are primarily driven by $3.2 million of compensation expenses for the retention of key employees acquired in the ChlorKing acquisition pursuant to the conditions in the acquisition agreement discussed above. Other adjustments for the year ended December 31, 2024 include $1.1 million of transaction and integration costs associated with the acquisition for the ChlorKing business, $0.9 million of termination benefits related to a reduction-in-force within E&RW, $0.8 million of separation and other costs associated with the centralization and consolidation of operations in Europe and $0.4 million of costs to finalize restructuring actions initiated in prior years. (e) Adjustments in the fiscal quarter ended December 31, 2025 are driven by $1.5 million for the settlement in principle of the securities class action litigation. Additional expenses will be paid by the Company's insurance carriers pursuant to the Company's retention amount with its insurance carriers. Adjustments in the fiscal quarter ended December 31, 2024 are primarily driven by a $1.6 million increase in cost of goods sold resulting from the fair value inventory step-up adjustment recognized as part of the purchase accounting for the acquisition of the ChlorKing business and $0.7 million of costs sustained from flood damage associated with a hurricane at a contract manufacturing facility. Adjustments in the year ended December 31, 2025 primarily include $4.3 million for the settlement in principle of the securities class action litigation. Expenses beyond the $4.3 million related to this case are subject to insurance recoveries pursuant to the Company’s retention amount with its insurance carriers. Other adjustments include $1.3 million of income from insurance proceeds related to flood damage associated with a hurricane at a contract manufacturing facility. Adjustments in the year ended December 31, 2024 are primarily driven by a $3.3 million increase in cost of goods sold resulting from the fair value inventory step-up adjustment recognized as part of the purchase accounting for the acquisition of the ChlorKing business, $0.7 million of costs sustained from flood damage associated with a hurricane at a contract manufacturing facility and $0.5 million of costs incurred related to litigation, partially offset by $0.5 million of gains on the sale of assets. (f) The tax effect represents the immediately preceding adjustments at the normalized tax rates as discussed in footnote (a) above. Segment Reconciliations Following is a reconciliation from segment income and segment income margin to adjusted segment income and adjusted segment income margin for the North America (“NAM”) and Europe & Rest of World (“E&RW”) segments: (Dollars in thousands) Three Months Ended Three Months Ended December 31, 2025 December 31, 2024 NAM E&RW NAM E&RW Segment income $ 102,543 $ 6,166 $ 95,089 $ 4,832 Depreciation 4,917 467 5,370 424 Amortization 1,769 — 2,111 — Other(a) 6 — 2,356 — Total adjustments 6,692 467 9,837 424 Adjusted segment income $ 109,235 $ 6,633 $ 104,926 $ 5,256 Segment income margin % 33.2 % 15.1 % 33.2 % 11.8 % Adjusted segment income margin % 35.4 % 16.3 % 36.7 % 12.8 % (a) Adjustments in the fiscal quarter ended December 31, 2025 for NAM represent losses on the sale of assets. Adjustments in the fiscal quarter ended December 31, 2024 for NAM are primarily driven by a $1.6 million increase in cost of goods sold resulting from the fair value inventory step-up adjustment recognized as part of the purchase accounting for the acquisition of the ChlorKing business and $0.7 million of costs sustained from flood damage associated with a hurricane at a contract manufacturing facility. (Dollars in thousands) Year Ended Year Ended December 31, 2025 December 31, 2024 NAM E&RW NAM E&RW Segment income $ 284,758 $ 26,540 $ 261,735 $ 21,632 Depreciation 19,540 1,761 17,989 1,215 Amortization 6,990 — 6,985 — Stock-based compensation(a) — — 176 10 Other(b) (605 ) — 4,079 — Total adjustments 25,925 1,761 29,229 1,225 Adjusted segment income $ 310,683 $ 28,301 $ 290,964 $ 22,857 Segment income margin % 29.7 % 16.3 % 29.2 % 13.9 % Adjusted segment income margin % 32.4 % 17.4 % 32.5 % 14.6 % (a) Represents non-cash stock-based compensation expense related to equity awards issued to management, employees, and directors. The adjustment includes only expense related to awards issued under the 2017 Equity Incentive Plan, which were awards granted prior to the effective date of the IPO. (b) Adjustments in the year ended December 31, 2025 for NAM primarily includes $0.6 million of insurance proceeds related to flood damage associated with a hurricane at a contract manufacturing facility. Adjustments in the year ended December 31, 2024 for NAM include a $3.3 million increase in cost of goods sold resulting from the fair value inventory step-up adjustment recognized as part of the purchase accounting for the acquisition of the ChlorKing business and $0.7 million of costs related to a flood sustained at a contract manufacturer. Source: Hayward Holdings, Inc.
View original release